Allergic reactions to the first COVID‐19 vaccine: A potential role of polyethylene glycol?

@article{Cabanillas2020AllergicRT,
  title={Allergic reactions to the first COVID‐19 vaccine: A potential role of polyethylene glycol?},
  author={B. Cabanillas and C. Akdis and N. Novak},
  journal={Allergy},
  year={2020},
  volume={76}
}
The COVID-19 vaccine developed by Pfizer and BioNTech was approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) on December 2nd 2020.1 MHRA is therefore the first regulator agency in the world to approve a vaccine to prevent coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus that is responsible for a global pandemic. 
Practical handling of allergic reactions to COVID-19 vaccines
Allergy to COVID-19 vaccines: A current update
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
...
1
2
3
4
...

References

SHOWING 1-8 OF 8 REFERENCES
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Immediate‐type hypersensitivity to polyethylene glycols: a review
  • E. Wenande, L. Garvey
  • Medicine
  • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2016
Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized.
Polyethylene glycol as a cause of anaphylaxis
Polyethylene Glycol Induced Systemic Allergic Reactions (Anaphylaxis).
Anti-PEG IgE In Anaphylaxis Associated with Polyethylene Glycol.